Cargando…
Economic burden of chronic bronchitis in the United States: a retrospective case-control study
BACKGROUND: Chronic bronchitis (CB) is often misdiagnosed or diagnosed at a later stage of chronic obstructive pulmonary disease (COPD). We examined how this later diagnosis may impact health care costs and utilization during the 12 months prior to and 24 months post initial CB diagnosis. METHODS: T...
Autores principales: | Blanchette, Christopher M, Roberts, Melissa H, Petersen, Hans, Dalal, Anand A, Mapel, Douglas W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034282/ https://www.ncbi.nlm.nih.gov/pubmed/21311695 http://dx.doi.org/10.2147/COPD.S15882 |
Ejemplares similares
-
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
por: Dalal, Anand A, et al.
Publicado: (2011) -
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
por: Mapel, Douglas W, et al.
Publicado: (2011) -
Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014) -
Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
por: Roberts, Melissa H., et al.
Publicado: (2019) -
The Epidemiology, Diagnosis, and Cost of Dyspepsia and Helicobater pylori Gastritis: A Case–Control Analysis in the Southwestern United States
por: Mapel, Douglas, et al.
Publicado: (2013)